Rahul Gandhi "best PM material": Veerappa Moily

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Belagavi, Mar 19: South Western Railway (SWR) on Thursday increased the fares of the platform tickets at Belagavi, Hubballi and Ballari.

The rate of platform tickets has been increased to Rs 50 with effect from Thursday till March 31, in order to control the crowding at platforms in view of the coronavirus outbreak.

Belagavi, Hubballi, and Bellari were all big stations and maximum number of people, including both passengers and those there to see them off come or to receive them at these railway stations, a SWR official sources said.

Bengaluru, Apr 14: The Karnataka government has decided to adopt “remote monitoring” of COVID-19 positive patients in order to ensure the safety of healthcare professionals - the frontline warriors against the pandemic.

Two doctors treating COVID-19 patients tested positive recently and in to check such instances in future, the Department of Medical Education is planning remote monitoring, which reduces doctors’ exposure to patients.

Medical Education Minister Dr K Sudhakar has consulted some of the doctors in the United States who are already using this technology to treat the COVID-19 positive cases. The minister is also having a meeting with representatives of some of the companies which provide such technology.

“I spoke to a team of epidemiologists and heads of certain departments at the United States to know about the remote monitoring technology they are using. I am also meeting the representatives of a few such companies which can provide us with the technology at our hospitals,”  Dr Sudhakar said.

Track state-wise coronavirus cases here

The minister added, “We have heard reports of many doctors and other health professionals succumbing to COVID-19. We don’t want to take risk.” Explaining the technology, Dr Sachidanand, Vice Chancellor of Rajiv Gandhi University of Health Sciences said that remote monitoring uses a software with which specialist doctors can monitor health condition of patients and treat them by not getting exposed directly.

The presence of all the doctors in COVID-19 is not necessary when patients are monitored remotely.